Search
Search Results
##search.searchResults.foundPlural##
-
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2361PDF: 831HTML: 15036 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
2769PDF: 1479HTML: 236 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
2805PDF: 876HTML: 384 -
Simultaneous dual pathology in lymph node
1490PDF: 629HTML: 7648Simultaneous dual pathology in lymph node: 131Simultaneous dual pathology in lymph node: 139Simultaneous dual pathology in lymph node: 122Simultaneous dual pathology in lymph node: 149Simultaneous dual pathology in lymph node: 136 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1018PDF: 713HTML: 282 -
Parvovirus B19 infection in a patient with common variable immunodeficiency Parvovirus B19 infection in a patient with common variable immunodeficiency
944PDF: 312HTML: 233 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
1888PDF: 1087HTML: 3630 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2314PDF: 760HTML: 8708Efremov 1: 160Efremov 2: 137 -
Guest Editor: G. Castaman AGING WITH HEMOPHILIA: THE CHALLENGE OF APPROPRIATE DRUG PRESCRIPTION Hemophilia and aging
1456PDF: 1344HTML: 181 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1230PDF: 846HTML: 1612Figure 1: 132 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
2904PDF: 1058HTML: 323 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
150PDF: 88Suppl. Files: 12HTML: 9 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
681PDF: 726HTML: 60 -
High Prevalence of Antiphospholipid Antibodies in Children with Non-Transfusion Dependent Thalassemia and Possible Correlations with Microparticles Antiphospholipid Antibodies and Thalassemia in children
680PDF: 519HTML: 231 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
960PDF: 446HTML: 8058 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3671PDF: 997HTML: 391 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1394PDF: 711HTML: 810jdoe, table 2 infections CML .doc: 146jdoe, table 1 infections CML .doc: 138 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1183PDF: 761HTML: 9951cover letter to the editor: 126tile page: 221 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1001PDF: 816HTML: 267 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1591PDF: 805HTML: 331Fig1: 176Fig.2: 195Fig. 3: 131Fig. 5: 142Fig. 4: 173 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2338PDF: 1505HTML: 2314Table1: 156 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3314PDF: 978HTML: 857 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1579PDF: 464HTML: 16939Figure 4: 124Figure 3: 109Figure 2: 103Figure 1: 125 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3298PDF: 1381HTML: 4069CoverLetter: 138Figure1: 149 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2855PDF: 778HTML: 7094Kost Fig1: 135Kost Fig 2: 126Kost Fig3: 124Kost Fig 4: 130Kost Fig5: 131Kost fig 6: 115







